Literature DB >> 21907891

Biotinidase deficiency presenting as recurrent myelopathy in a 7-year-old boy and a review of the literature.

Sarbani Raha1, Vrajesh Udani.   

Abstract

Biotinidase deficiency may produce variable neurologic manifestations. Brainstem and spinal cord disease comprises an uncommon presentation of biotinidase deficiency. We describe a 7-year old boy with subacute progressive quadriplegia and "sighing" respirations. Severe biotinidase deficiency was established, and the patient demonstrated complete recovery with biotin supplementation. Genetic studies revealed presence of homozygous mutation in the BTD gene [c.133C>T (p.H447Y)]. Biotinidase deficiency should be considered in the differential diagnosis for subacute, long segment myelopathy, particularly with brainstem involvement. This entity is treatable; a high index of suspicion can be life-saving. We also review the literature on biotinidase deficiency presenting as spinal cord demyelinating disease.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21907891     DOI: 10.1016/j.pediatrneurol.2011.06.010

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  8 in total

1.  Status of Newborn Screening and Inborn Errors of Metabolism in India.

Authors:  Seema Kapoor; B K Thelma
Journal:  Indian J Pediatr       Date:  2018-05-07       Impact factor: 1.967

2.  Novel imaging findings in two cases of biotinidase deficiency-a treatable metabolic disorder.

Authors:  Maya Dattatraya Bhat; P S Bindu; Rita Christopher; Chandrajit Prasad; Abha Verma
Journal:  Metab Brain Dis       Date:  2015-06-04       Impact factor: 3.584

3.  Detection of biotinidase gene mutations in Turkish patients ascertained by newborn and family screening.

Authors:  Mehmet Karaca; Rıza Köksal Özgül; Özlem Ünal; Didem Yücel-Yılmaz; Mustafa Kılıç; Burcu Hişmi; Ayşegül Tokatlı; Turgay Coşkun; Ali Dursun; Hatice Serap Sivri
Journal:  Eur J Pediatr       Date:  2015-03-11       Impact factor: 3.183

4.  A Treatable Cause of Myelopathy: Biotinidase Deficiency Presenting as Acute Flaccid Paralysis.

Authors:  Vykuntaraju K Gowda; Chetan Kerur; Dhananjaya K Vamyanmane; Pragalatha Kumar; Vani H Nagarajappa; Sanjay K Shivappa
Journal:  J Pediatr Genet       Date:  2020-10-08

5.  Expert consensus on screening, diagnosis and treatment of multiple carboxylase deficiency.

Authors:  Division of Biochemistry and Metabolism, Medical Genetics Branch Chinese Medical Association; Division of Genetics and Metabolism, Child Diseases and Health Care Branch Chinese Association for Maternal and Child Health; Division of Genetics and Metabolism, Rare Diseases Committee of Beijing Medical Association
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2022-02-25

Review 6.  Biotinidase Deficiency: Prevalence, Impact And Management Strategies.

Authors:  Ebru Canda; Sema Kalkan Uçar; Mahmut Çoker
Journal:  Pediatric Health Med Ther       Date:  2020-05-04

7.  Late Onset Subacute Profound Biotinidase Deficiency Caused by a Novel Homozygous Variant c.466-3T>G in the BTD Gene.

Authors:  Kaustubh Mohite; Karthik Vijay Nair; Anilkumar Sapare; Venkatraman Bhat; Anju Shukla; Minal Kekatpure; Siddaramappa J Patil
Journal:  Indian J Pediatr       Date:  2022-01-14       Impact factor: 5.319

8.  Severe Distal Motor Involvement in a Non-compliant Adult With Biotinidase Deficiency: The Necessity of Life-Long Biotin Therapy.

Authors:  Géraldine Van Winckel; Diana Ballhausen; Barry Wolf; Melinda Procter; Rong Mao; Patricie Burda; Davide Strambo; Thierry Kuntzer; Christel Tran
Journal:  Front Neurol       Date:  2020-10-26       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.